Filing Details

Accession Number:
0001181431-13-016742
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-13 18:11:42
Reporting Period:
2013-03-11
Filing Date:
2013-03-13
Accepted Time:
2013-03-13 18:11:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484478 Furiex Pharmaceuticals Inc. FURX Pharmaceutical Preparations (2834) 271197863
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1507502 W Stephen Kaldor C/O Furiex Pharmaceuticals, Inc.
3900 Paramount Parkway, Suite 150
Morrisville NC 27560
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-11 8,000 $13.94 8,000 No 4 M Direct
Common Stock Disposition 2013-03-11 5,379 $41.74 2,621 No 4 S Direct
Common Stock Disposition 2013-03-12 973 $40.71 1,648 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (to buy) Disposition 2013-03-11 8,000 $0.00 8,000 $13.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,012 2021-05-19 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (to buy) $13.45 2021-10-12 8,825 8,825 Direct
Common Stock Stock Options (to buy) $18.22 2022-05-24 17,500 17,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-10-12 8,825 8,825 Direct
2022-05-24 17,500 17,500 Direct
Footnotes
  1. The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
  2. The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
  3. The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.